Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kivexa + Efavirenz vs Kivexa + Kaletra in Naive HIV-1 Patients
NCT00318123Phase 3Completed
- Sponsor
- Hospital Universitari Germans Trias i Pujol
- Start
- Apr 2004
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of abacavir + lamivudine in human immunodeficiency virus infection (HIV), sponsored by Hospital Universitari Germans Trias i Pujol. Started Apr 2004; status: completed.
02
Drugs
abacavir + lamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00318123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00318123.